|
|
|
|
| LEADER |
02142nam a22004455i 4500 |
| 001 |
978-3-642-14816-3 |
| 003 |
DE-He213 |
| 005 |
20151125201545.0 |
| 007 |
cr nn 008mamaa |
| 008 |
101029s2011 gw | s |||| 0|eng d |
| 020 |
|
|
|a 9783642148163
|9 978-3-642-14816-3
|
| 024 |
7 |
|
|a 10.1007/978-3-642-14816-3
|2 doi
|
| 040 |
|
|
|d GrThAP
|
| 050 |
|
4 |
|a RC261-271
|
| 072 |
|
7 |
|a MJCL
|2 bicssc
|
| 072 |
|
7 |
|a MED062000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 614.5999
|2 23
|
| 245 |
1 |
0 |
|a Phosphoinositide 3-kinase in Health and Disease
|h [electronic resource] :
|b Volume 2 /
|c edited by Christian Rommel, Bart Vanhaesebroeck, Peter K. Vogt.
|
| 264 |
|
1 |
|a Berlin, Heidelberg :
|b Springer Berlin Heidelberg :
|b Imprint: Springer,
|c 2011.
|
| 300 |
|
|
|a X, 306 p. 79 illus., 46 illus. in color.
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
|
|
|a text file
|b PDF
|2 rda
|
| 490 |
1 |
|
|a Current Topics in Microbiology and Immunology,
|x 0070-217X ;
|v 347
|
| 520 |
|
|
|a From humble beginnings over 25 years ago as a lipid kinase activity associated with certain oncoproteins, PI3K (phosphoinositide 3-kinase) has been catapulted to the forefront of drug development in cancer, immunity and thrombosis, with the first clinical trials of PI3K pathway inhibitors now in progress. Here the authors give a brief overview of some key discoveries in the PI3K area and their impact, and include thoughts on the current state of the field, and where it could go from here.
|
| 650 |
|
0 |
|a Medicine.
|
| 650 |
|
0 |
|a Cancer research.
|
| 650 |
1 |
4 |
|a Biomedicine.
|
| 650 |
2 |
4 |
|a Cancer Research.
|
| 700 |
1 |
|
|a Rommel, Christian.
|e editor.
|
| 700 |
1 |
|
|a Vanhaesebroeck, Bart.
|e editor.
|
| 700 |
1 |
|
|a Vogt, Peter K.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 776 |
0 |
8 |
|i Printed edition:
|z 9783642148156
|
| 830 |
|
0 |
|a Current Topics in Microbiology and Immunology,
|x 0070-217X ;
|v 347
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1007/978-3-642-14816-3
|z Full Text via HEAL-Link
|
| 912 |
|
|
|a ZDB-2-SBL
|
| 950 |
|
|
|a Biomedical and Life Sciences (Springer-11642)
|
